Eqis Capital Management, Inc. Veru Inc. Transaction History

Eqis Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 27, 2018	SELL	$1.64 - $2.29 $52,389 - $73,154	-31,945 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$1.19 - $2.17 $47 - $86	40 Added 0.13%	31,945 $58,000
Q4 2017 Jan 25, 2018	BUY	$0.98 - $2.27 $1,484 - $3,439	1,515 Added 4.99%	31,905 $36,000
Q3 2017 Oct 03, 2017	BUY	$1.2 - $2.84 $36,468 - $86,307	30,390	30,390 $81,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.